Corticosteroids and outcome in children undergoing congenital heart surgery: Analysis of the pediatric health information systems database

Circulation

Volumn 122, Issue 21, 2010, Pages 2123-2130

  Pasquali, Sara K ^a,b   Hall, Matthew ^c   Li, Jennifer S ^a,b   Peterson, Eric D ^a,b   Jaggers, James ^a   Lodge, Andrew J ^a   Marino, Bradley S ^d   Goodman, Denise M ^e   Shah, Samir S ^f  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Child Health Corporation of America   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

drugs; pediatrics; surgery

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; INSULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INFANT; INFECTION RATE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADRENAL CORTEX HORMONES; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MORBIDITY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 78650178833     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.948737     Document Type: Article

References (41)

1. Checchia PA, Bronicki RA, Costello JM, Nelson DP. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: an international survey of 36 centers. Pediatr Crit Care Med. 2005;6:441-444. (Pubitemid 40980824)
2. Lindberg L, Forsell C, Jogi P, Olsson K. Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after pediatric cardiac surgery. Br J Anaesth. 2003;90: 728-732. (Pubitemid 36700774)
3. Bronicki R, Backer C, Baden H, Mavroudis C, Crawford S, Green T. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2000;69:1490-1495. (Pubitemid 30434881)
4. Schroeder V, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation. 2003;107:2823-2828. (Pubitemid 36705993)
5. Varan B, Tokel K, Mercan S, Donmez A, Aslamaci S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Pediatr Cardiol. 2002;23:437-441. (Pubitemid 36927867)
6. Robertson-Malt S, Afrane B, Elbarbary M. Prophylactic steroids for pediatric open heart surgery. Cochrane Database Syst Rev. 2007: CD005550.
7. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123:110-118.
8. Welke KF, Diggs BS, Karamlou T, Ungerleider RM. Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg. 2009;87:216-223.
9. Larsen SH, Pedersen J, Jacobsen J, Johnsen SP, Hansen OK, Hjortdal V. The RACHS-1 risk categories reflect mortality and length of stay in a Danish population of children operated for congenital heart disease. Eur J Cardiothorac Surg. 2005;28:877-881. (Pubitemid 41735268)
10. Checchia PA, Karamlou T, Maruszewski B, Ohye RG, Bronicki R, Dodge-Khatami A. Haematological and infectious complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008;18: 226-233.
11. Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006;59:437-447.
12. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
13. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004;13:841-853. (Pubitemid 40003819)
14. Imbens GW. Nonparametric estimation of average treatment effects under erogeneity: a review. Rev Econ Stat. 2004;86:4-29. (Pubitemid 38422764)
15. Greenland S. Introduction to regression modeling. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2008:446-451.
16. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716-723.
17. Duval E, Kavelaars A, Veenhuizen L, van Vught AJ, van de Wal HJ, Heijnen CJ. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. Eur J Pediatr. 1999;158:387-393. (Pubitemid 29198194)
18. Friedrich B, Schmidt R, Reiss I, Gunther A, Seeger W, Muller M, Thul J, Schranz D, Gorter L. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children. Crit Care Med. 2003;31:284-290. (Pubitemid 36151186)
19. Bonferroni CE. Il calcolo delle assicurazioni su gruppi di teste. In: Carboni SO, ed. Studi in Onore del Professore Salvatore Ortu Carboni. Rome, Italy; 1935:13-60.
20. Casey LC. Roles of cytokines in the pathogenesis of cardiopulmonary- induced multisystem organ failure. Ann Thorac Surg. 1993;56:S92-S96. (Pubitemid 23328711)
21. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997;63:277-284. (Pubitemid 27039090)
22. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaestesiol Scand. 2001;45:671-679. (Pubitemid 32613457)
23. Teoh KH, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine mediated vasodilation after warm heart surgery. Circulation. 1995;92(suppl):II-347-II-353.
24. Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, Teoh KH. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J. 2008; 29:2592-2600.
25. Steroids in Cardiac Surgery Trial (SIRS Trial). Available at: http://www. clinicaltrials.gov/ct2/show/NCT00427388?term = sirs + trial&rank = 1. Accessed November 24, 2009.
26. Dexamethasone for Cardiac Surgery Trial. Available at: http://www. clinicaltrials.gov/ct2/show/NCT00293592?term=nct00293592&rank=1. Accessed November 24, 2009.
27. Jansen NJG, van Oeveren W, van Vilet M, Stoutenbeek CP, Eysman L, Wildevuur CRH. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1991;5:211-217.
28. Lodge AJ, Chai PJ, Daggett CW, Ungerleider RM, Jaggers J. Methylpred-nisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg. 1999;117:515-522. (Pubitemid 29117532)
29. Jensen E, Andreasson S, Bengtsson A, Berggren H, Ekroth R, Lindholm L, Ouchterlong J. Influence of two difference perfusion systems on inflammatory response in pediatric heart surgery. Ann Thorac Surg. 2003;75:919-925. (Pubitemid 36298369)
30. Ghafoori AF, Twite MD, Friesen RH. Postoperative hyperglycemia is associated with mediastinitis following pediatric cardiac surgery. Pediatr Anesth. 2008;18:1202-1207.
31. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004;5:329-336.
32. Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, Cua CL. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patients. Pediatr Crit Care Med. 2006;7:351-355. (Pubitemid 44048279)
33. Barker GM, O'Brien SM, Welke KF, Jacobs ML, Jacobs JP, Benjamin DK Jr, Peterson ED, Jaggers J, Li JS. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg. 2010;89: 843-850.
34. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation. 2009;119: 1853-66.
35. Holzmann-Pazgal G, Hopkins-Broyles D, Recktenwald A, Hohrein M, Kieffer P, Huddleston C, Anshuman S, Fraser V. Case-control study of pediatric cardiothoracic surgical site infections. Infect Control Hosp Epidemiol. 2008;29:76-79. (Pubitemid 351267780)
36. Mahle WT, Visconti KJ, Freier C, Kanne SM, Hamilton WG, Sharkey AM, Chinnock RE, Jenkins KJ, Isquith PK, Burns TG, Jenkins PC. Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome. Pediatrics. 2006;117:e90-e97. (Pubitemid 46050505)
37. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open-heart operations. Ann Thorac Surg. 1993;56:1518-1522. (Pubitemid 24042707)
38. Andreasson S, Gothberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemofiltration modifies complement activation after extra-corporeal circulation in infants. Ann Thorac Surg. 1993;56:1515-1517. (Pubitemid 24042706)
39. Benzing G, Fancis PD, Kaplan S, Helmsworth JA, Sperling MA. Glucose and insulin changes in infants and children undergoing hypothermic open-heart surgery. Am J Cardiol. 1983;52:133-136. (Pubitemid 13061340)
40. Doenst T, Wijevsundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is and independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144.e1-1144.e8.
41. Jacobs JP, Jacobs ML, Lacour-Gayet FG, Jenkins KJ, Gauvreau K, Bacha E, Maruszewski B, Clarke DR, Tchervenkov CI, Gaynor JW, Spray TL, Stellin G, O'Brien SM, Elliott MJ, Mavroudis C. Stratification of complexity improves the utility and accuracy of outcomes analysis in a multi-institutional congenital heart surgery database: application of the Risk Adjustment in Congenital Heart Surgery (RACHS-1) and Aristotle systems in the Society of Thoracic Surgeons Congenital Heart Surgery Database. Pediatr Cardiol. 2009;30:1117-1130.